Enzymotec Announces New Patents in US, Australia Related to Relevant to Phospholipid-Based Products

Enzymotec Ltd. ENZY ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it has been granted new patents by the U.S. Patent and Trademark Office and the Australian Patent Office for certain phospholipid-based compositions that cover several of the Company's products. The granted patents cover a wide variety of phospholipid based compositions that include long chain poly-unsaturated fatty acids, and are pertinent to a number of Enzymotec's products, such as the K•REAL® krill oil products and additional advanced phospholipid products. These additions to Enzymotec's broad patent portfolio are the result of the Company's efforts to continually maintain and reinforce the protection of its products. Dr. Ariel Katz, President and Chief Executive Officer of Enzymotec, commented, "As experts in specialty phospholipid-based products, we are excited by the further strengthening of our portfolio of intellectual property with these important patents. Our products are strong leaders in the market, driven by our specialized technologies and supported with an enforceable patent portfolio. These new patents are demonstrative of our commitment to innovation and provide our customers with exceptional ingredients of the highest quality."